Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
European Heart Journal|January 22, 2010
Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionMarten Trendelenburg, Pierre Theroux, Amanda Stebbins, et al.
JACC. Cardiovascular Interventions|March 21, 2025
Temporal Trends in 1-Year Cause-Specific Mortality After TAVR: Insights From the STS/ACC TVT RegistryDhaval Kolte, Guillaume Marquis-Gravel, Amanda Stebbins, et al.
Journal of the American Heart Association|December 31, 2021
Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT RegistryTanyanan Tanawuttiwat, Amanda Stebbins, Guillaume Marquis-Gravel, et al.
Structural Heart : the Journal of the Heart Team|April 29, 2026
Sex and Racial Disparities in Outcomes of Transcatheter Edge-to-Edge Mitral Valve Repair for Functional Mitral Regurgitation: A Multicenter Prospective AnalysisKyeeun Park, Amanda Stebbins, Sunwoo Han, et al.
American Heart Journal|July 17, 2012
Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trialCatherine Martel, Christopher B Granger, Marta Ghitescu, et al.
Journal of the American College of Cardiology|November 4, 2017
Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry ReportPaul Sorajja, Sreekanth Vemulapalli, Ted Feldman, et al.
American Heart Journal|August 10, 2010
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) SubstudyJustin A Ezekowitz, Paul W Armstrong, Christopher B Granger, et al.
Structural Heart : the Journal of the Heart Team|February 13, 2026
Impact of Changes in Renal Function on Outcomes Following Mitral Transcatheter Edge-To-Edge RepairParth N Patel, Olivia L Hulme, Marc Allard-Ratick, et al.
American Heart Journal|February 28, 2025
Clinical outcomes of direct oral anticoagulant versus warfarin after transcatheter aortic valve replacement: From the STS/ACC TVT registryTomo Ando, Tamim Nazif, Alexandros Briasoulis, et al.
Journal of the American College of Cardiology|September 20, 2022
Transcatheter Edge-to-Edge Mitral Valve Repair in Patients With Severe Mitral Regurgitation and Cardiogenic ShockTrevor Simard, Sreek Vemulapalli, Richard G Jung, et al.
Pageof 8